EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Factors Associated with MASLD and Its Association with Carotid Atherosclerotic Burden in Dyslipidemic Primary Care Patients: A Cross-Sectional Study

Marcin Hachuła, Magdalena Woś, Bogusław Okopień

Metabolites · 15.11.2026 · 16 (11) · 892

DOI: 10.3390/metabo16110892 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Metabolites, online erschienen am 15.11.2026. Verfasst von Marcin Hachuła und 2 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) and atherosclerosis often occur together and share the same metabolic risk factors. The aim of our study was to assess the prevalence of MASLD and factors associated with it in primary care patients with dyslipidemia (n = 600) and, in the subgroup with ultrasound-confirmed carotid atherosclerosis (n = 407), to check whether MASLD is associated with the extent of atherosclerotic changes and to explore the role of non-invasive liver indices (Fibrosis-4 index [FIB-4], aspartate aminotransferase-to-platelet ratio index [APRI], De Ritis ratio and Fatty Liver Index [FLI]).

Methods

The study included 600 people with diagnosed dyslipidemia enrolled in the cardiology coordinated-care pathway in primary care. Atherosclerotic burden was analyzed in the subgroup with carotid atherosclerosis (n = 407). MASLD was diagnosed based on abdominal ultrasound. Multivariable logistic regression, adjusted for age, sex and cardiometabolic factors, was used to identify factors associated with MASLD. Associations of MASLD with atherosclerotic burden were assessed by linear and ordinal regression adjusted for age and sex and, in additional models, adjusted for diabetes, hypertension, body mass index (BMI), smoking, low-density lipoprotein cholesterol (LDL-C), statin use and estimated glomerular filtration rate (eGFR). FIB-4, APRI, the De Ritis ratio and the Fatty Liver Index (FLI) were calculated for all patients.

Results

MASLD was present in 45% of patients. Patients with MASLD had higher BMI, waist circumference, triglycerides, uric acid and liver enzymes and lower high-density lipoprotein cholesterol (HDL-C) (p < 0.001 for all). Carotid atherosclerosis itself was not associated with MASLD after adjustment for age, sex, BMI, diabetes, hypertension, triglycerides, HDL-C and uric acid (odds ratio (OR) 0.90, 95% confidence interval (CI) 0.52–1.55). Age, BMI, type 2 diabetes (OR 1.85), hypertension (OR 2.01) and triglycerides were factors associated with MASLD. In patients with confirmed carotid atherosclerosis (n = 407), MASLD was associated with greater atherosclerotic burden after adjustment for age and sex (bilateral involvement OR 1.80, stenosis ≥ 50% (21 events) OR 3.64, 95% CI 1.14–11.66 (Firth), larger plaque diameter; all p < 0.05), and the association with the burden score and plaque diameter persisted after additional adjustment for diabetes, hypertension, BMI, smoking, LDL-C, statin use and eGFR (burden score β = 0.35, 95% CI 0.19–0.52), whereas the association with bilateral involvement was attenuated after adjustment for diabetes and hypertension (OR 1.55, 95% CI 0.93–2.59) and recovered in the full model (OR 1.90, 95% CI 1.08–3.32). There was no evidence of an association with plaque hypoechogenicity (p = 0.87). No such association was found for FIB-4, APRI or the De Ritis ratio after adjustment for age. FLI showed modest accuracy in identifying patients with MASLD (area under the curve (AUC) 0.72, 95% CI 0.68–0.76); the Youden cut-off (FLI ≥ 47) was unstable and exploratory (positive predictive value (PPV) 61%, negative predictive value (NPV) 73%), and at the conventional cut-offs, NPV was 77% for FLI < 30 and PPV 65% for FLI ≥ 60.

Conclusions

In primary care patients with dyslipidemia, MASLD is associated mainly with classic metabolic risk factors and not with the presence of atherosclerosis itself. In patients who already have atherosclerosis, MASLD is associated with more extensive atherosclerotic changes, with no evidence of an association with plaque hypoechogenicity. Larger, prospective studies are needed to confirm these findings.

Zitieren

APA

Hachuła, M., Woś, M., & Okopień, B. (2026). Factors Associated with MASLD and Its Association with Carotid Atherosclerotic Burden in Dyslipidemic Primary Care Patients: A Cross-Sectional Study. Metabolites, 16(11), 892. https://doi.org/10.3390/metabo16110892

Vancouver

Hachuła M, Woś M, Okopień B. Factors Associated with MASLD and Its Association with Carotid Atherosclerotic Burden in Dyslipidemic Primary Care Patients: A Cross-Sectional Study. Metabolites. 2026;16(11):892. doi:10.3390/metabo16110892

BibTeX
@article{Hachua2026,
  author = {Hachuła, Marcin and Woś, Magdalena and Okopień, Bogusław},
  title = {Factors Associated with MASLD and Its Association with Carotid Atherosclerotic Burden in Dyslipidemic Primary Care Patients: A Cross-Sectional Study},
  journal = {Metabolites},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {892},
  doi = {10.3390/metabo16110892}
}
Kostenlos starten →